Update on Clinical Aspects of Chronic Obstructive Pulmonary Disease | NEJM Skip to main
content NEJM Group Follow Us Facebook Twitter Instagram YouTube LinkedIn Prepare to …

The efficacy, safety and positioning of inhaled corticosteroids (ICS) in the treatment of
patients with chronic obstructive pulmonary disease (COPD) is much debated, since it can …

Background Combinations of long-acting bronchodilators are recommended to reduce the
rate of chronic obstructive pulmonary disease (COPD) exacerbations. It is unclear whether …

Acute exacerbations of chronic obstructive pulmonary disease (COPD) are associated with a
significant mortality, health and economic burden. Their diagnosis, assessment and …

Inhaled corticosteroids (ICS) combined with bronchodilators can reduce the frequency of
exacerbations in some patients with chronic obstructive pulmonary disease (COPD). There …

Das vorliegende Dokument ist eine Neufassung und Aktualisierung der Leitlinie zur
Diagnostik und Therapie von Patienten mit COPD, die die bisherige Version aus dem Jahr …

Rationale: Early detection of chronic obstructive pulmonary disease (COPD) exacerbations
using telemonitoring of physiological variables might reduce the frequency of …

Chronic obstructive pulmonary disease (COPD) was the fourth leading cause of death
worldwide in 2015. Current treatments for patients ease discomfort and help decrease …

Oxidative stress contributes to chronic obstructive pulmonary disease (COPD) exacerbations
and antioxidants can decrease exacerbation rates, although we lack data about the effect of …

Over the last few years, there has been a renewed interest in patients with characteristics of
both asthma and COPD. Although the precise definition of asthma-COPD overlap (ACO) is …